Publication: Consensus on the development of vaccines against naturally acquired melioidosis
Issued Date
2015-06-01
Resource Type
ISSN
10806059
10806040
10806040
Other identifier(s)
2-s2.0-84981749578
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Emerging Infectious Diseases. Vol.21, No.6 (2015), e1-e7
Suggested Citation
Direk Limmathurotsakul, Simon G.P. Funnell, Alfredo G. Torres, Lisa A. Morici, Paul J. Brett, Susanna Dunachie, Timothy Atkins, Daniel M. Altmann, Gregory Bancroft, Sharon J. Peacock Consensus on the development of vaccines against naturally acquired melioidosis. Emerging Infectious Diseases. Vol.21, No.6 (2015), e1-e7. doi:10.3201/eid2106.141480 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/36429
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Consensus on the development of vaccines against naturally acquired melioidosis
Other Contributor(s)
Abstract
© 2015, Marmara University. All rights reserved. Several candidates for a vaccine against Burkholderia pseudomallei, the causal bacterium of melioidosis, have been developed, and a rational approach is now needed to select and advance candidates for testing in relevant nonhuman primate models and in human clinical trials. Development of such a vaccine was the topic of a meeting in the United Kingdom in March 2014 attended by international candidate vaccine developers, researchers, and government health officials. The focus of the meeting was advancement of vaccines for prevention of natural infection, rather than for protection from the organism’s known potential for use as a biological weapon. A direct comparison of candidate vaccines in well-characterized mouse models was proposed. Knowledge gaps requiring further research were identified. Recommendations were made to accelerate the development of an effective vaccine against melioidosis.